Head and Neck Cancer Market Growth and Competitive Landscape to 2026

Head and Neck Cancer Market Size, Share,
Trend, Outlook, Future Growth Analysis
And Synthesis By 2026
Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called
tumor. This tumor can be cancerous or benign. Head and neck cancer is the terminology used to define
a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and
mouth. Furthermore, head and neck cancers initiate in squamous cells, cells that line moist surfaces such
as those inside the head and neck (for example, the mouth, nose, and throat). Salivary glands have
different types of cells that can turn cancerous. Chewing tobacco, excessive alcohol consumption, and
infection with human papillomavirus (HPV) increases the risk of head and neck cancer. Other risk factors
for head and neck cancers include excessive consumption of paan (betel quid), preserved or salted foods,
oral health, occupational exposure, radiation exposure, Epstein barr virus infection, and due to
hereditary causes.
Request For Sample Copy of This Research: https://www.coherentmarketinsights.com/insight/requestsample/530
Need for effective and targeted treatment is critical to increase the survival rates
Treatment of head and neck cancer is a major challenge for physicians, as the affectivity and choice of
treatment varies from patient to patient and location of the tumor. Owing to complexity of facial
structures and functions limits the surgical treatments for head and neck cancers, with surgery being the
preferred mode of treatment. Post-surgery, functions such as chewing, talking, and swallowing may be
adversely affected. Physicians opt for surgical therapy in combination with radiation therapy for
treatment of the malady. Survival rate of head and neck cancer has reduced from 80% to 50% in last
ten years, as currently available treatment options mainly treat the symptoms. Recent developments in
the area of advanced chemotherapy and radiotherapy permit preserving some of the functions of the
face. The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, and
antibody drug conjugates creates major growth avenues for the head and neck cancer market.
High incidence rate creates a potential growth opportunity for the market players
Growing occurrence of head and neck cancer and increasing research activities to develop costeffective treatment options are the factors which are driving growth of the global head and
neck cancer market. According to the World Health Organization, 3 - 5% of the population
around the globe suffers from head and neck cancer. Moreover, worldwide approximately
550,000 new cases of head and neck cancer are diagnosed annually with almost 300,000 deaths
annually. While the cancer can affect people across different age groups, it is especially
prevalent among people over 50 years of age. Head and neck cancer is projected to result in
13,360 fatalities (3,420 women and 9,940 men) in 2017. These types of cancers are more than
twice as common among men as women.
Report includes chapters which deeply display the following deliverable about industry :
• Head and Neck Cancer Market Research Objective and Assumption
• Head and Neck Cancer Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Head and Neck Cancer Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Head and Neck Cancer Market, By Regions
• Head and Neck Cancer Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Head and Neck Cancer Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Head and Neck Cancer Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Head and Neck Cancer Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Global Top Players -
Key players operating in the head and neck cancer market are AB Science SA, Bayer AG, Bristol-Myers
Squibb Company, Acceleron Pharma, Inc., Astellas Pharma Inc., Boston Biomedical, Inc., AbbVie Inc.,
and AstraZeneca Plc.
Head And Neck Cancer Market Taxonomy -
On the basis of disease indication, the global head and neck cancer market is classified into:
•
Laryngeal and Hypopharyngeal Cancer
•
Nasal Cavity and Paranasal Sinus Cancer
•
Nasopharyngeal Cancer
•
Oral and Oropharyngeal Cancer
•
Salivary Gland Cancer
On the basis of diagnostic methods, the global head and neck cancer market is classified into:
•
Diagnostic imaging equipment
•
Endoscopy screening equipment
•
Bioscopy screening tests
•
Blood tests
•
Dental diagnostic
Browse Full Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/headand-neck-cancer-market-530
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign.